Tanya Troy
YOU?
Author Swipe
View article: Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 5: Effect of HPV16 qPCR copynumber(CN) per cell on HPV16 infections.
View article: Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Background:Effective screening for oropharyngeal cancer is lacking. Four oncogenic HPV clearance definitions were explored to understand long-term natural history for persistent oncogenic oral HPV (oncHPV), the precursor of oropharyngeal c…
View article: Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 5: Effect of HPV16 qPCR copynumber(CN) per cell on HPV16 infections.
View article: Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 2: Multivariate predictors of clearance, across the four different clearance definitions evaluated in this study.
View article: Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
View article: Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 2: Multivariate predictors of clearance, across the four different clearance definitions evaluated in this study.
View article: Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 4: Effect of sex on prevalent (SF4a) incident (SF4b) infections.
View article: Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 6: Effect of HIV and CD4 on prevalent (SF6a) incident (SF6b) infections.
View article: Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 1: Proportion of 1833 subjects screened who have oncogenic oral HPV DNA and cancer characteristics.
View article: Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Data from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Background:Effective screening for oropharyngeal cancer is lacking. Four oncogenic HPV clearance definitions were explored to understand long-term natural history for persistent oncogenic oral HPV (oncHPV), the precursor of oropharyngeal c…
View article: Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 3: Effect of age on prevalent (SF3a) incident (SF3b) infections.
View article: Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 4: Effect of sex on prevalent (SF4a) incident (SF4b) infections.
View article: Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 2: Clearance of prevalent (panel A) and incident (panel B) oral HPV16 infections over 10 years
View article: Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 1: Flowchart of the 1833 MACS and WIHS participants in the POPS, how many had oncogenic oral HPV DNA, and how many had additional follow-up of uncleared infections as part of the MOUTH study.
View article: Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 6: Effect of HIV and CD4 on prevalent (SF6a) incident (SF6b) infections.
View article: Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
View article: Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 1: Flowchart of the 1833 MACS and WIHS participants in the POPS, how many had oncogenic oral HPV DNA, and how many had additional follow-up of uncleared infections as part of the MOUTH study.
View article: Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 3: Effect of age on prevalent (SF3a) incident (SF3b) infections.
View article: Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Table 1: Proportion of 1833 subjects screened who have oncogenic oral HPV DNA and cancer characteristics.
View article: Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Supplemental Figure 2: Clearance of prevalent (panel A) and incident (panel B) oral HPV16 infections over 10 years
View article: Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years Open
Background: Effective screening for oropharyngeal cancer is lacking. Four oncogenic HPV clearance definitions were explored to understand long-term natural history for persistent oncogenic oral HPV (oncHPV), the precursor of oropharyngeal …
View article: Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study
Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study Open
Background Human papillomavirus (HPV)‐related oropharyngeal cancer screening is being explored in research studies, but strategies to identify an appropriate population are not established. The authors evaluated whether a screening populat…
View article: Data from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Data from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer Open
Performance of commercially available human papillomavirus (HPV) assays (approved for cervical HPV detection) is unknown for detecting HPV-related oropharyngeal cancer (HPV-OPC). Assays for detection of HPV DNA [ELISA (DEIA) and Cobas], an…
View article: Supplementary Table 1 from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Supplementary Table 1 from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer Open
Supplementary Table 1
View article: Supplementary Table 1 from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Supplementary Table 1 from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer Open
Supplementary Table 1
View article: Data from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Data from Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer Open
Performance of commercially available human papillomavirus (HPV) assays (approved for cervical HPV detection) is unknown for detecting HPV-related oropharyngeal cancer (HPV-OPC). Assays for detection of HPV DNA [ELISA (DEIA) and Cobas], an…
View article: Feasibility of clinical evaluation of individuals with increased risk for HPV‐associated oropharynx cancer
Feasibility of clinical evaluation of individuals with increased risk for HPV‐associated oropharynx cancer Open
Background Human papillomavirus‐associated oropharynx squamous cell carcinoma (HPV‐OPSCC) has no known pre‐malignant lesion. While vaccination offers future primary prevention, there is current interest in secondary prevention. The feasibi…
View article: Association of Plasma Circulating Tumor HPV DNA With HPV-Related Oropharynx Cancer
Association of Plasma Circulating Tumor HPV DNA With HPV-Related Oropharynx Cancer Open
This cross-sectional analysis examines whether circulating tumor human papillomavirus DNA is detectable in the plasma of healthy participants at risk for oral human papillomavirus infection and the agreement with oral rinse and serum bioma…
View article: Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time
Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time Open
BACKGROUND Human papillomavirus (HPV) is responsible for a growing proportion of oropharyngeal squamous cell carcinomas (OPSCCs) among men and White individuals. Whether similar trends apply to women, non‐Whites, and non‐oropharyngeal squa…
View article: Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma
Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma Open